Ligand Pharmaceuticals, Inc. - Class B


LGND

Price

72.775


Change

1.505


High

NA


Low

71.12


Avg Volume

227,575


PE Ratio

24.75


52 Week High

94.57


52 Week Low

49.24



Profile

Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenx Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. Since 2005, the company has twice restated its financial accounts, and it has been subject to class action lawsuits. Fortune ranked Ligand as among the top 100 fastest growing companies for 2014-2016, and in 2018 its CEO was listed among the top five highest paid CEOs in San Diego.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.